An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care.

BACKGROUND:The development of genotyping and genetic sequencing techniques and their evolution towards low costs and quick turnaround have encouraged a wide range of applications. One of the most promising applications is pharmacogenomics, where genetic profiles are used to predict the most suitable...

Full description

Bibliographic Details
Main Authors: Jose Antonio Miñarro-Giménez, Kathrin Blagec, Richard D Boyce, Klaus-Peter Adlassnig, Matthias Samwald
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4008421?pdf=render
_version_ 1811207502762606592
author Jose Antonio Miñarro-Giménez
Kathrin Blagec
Richard D Boyce
Klaus-Peter Adlassnig
Matthias Samwald
author_facet Jose Antonio Miñarro-Giménez
Kathrin Blagec
Richard D Boyce
Klaus-Peter Adlassnig
Matthias Samwald
author_sort Jose Antonio Miñarro-Giménez
collection DOAJ
description BACKGROUND:The development of genotyping and genetic sequencing techniques and their evolution towards low costs and quick turnaround have encouraged a wide range of applications. One of the most promising applications is pharmacogenomics, where genetic profiles are used to predict the most suitable drugs and drug dosages for the individual patient. This approach aims to ensure appropriate medical treatment and avoid, or properly manage, undesired side effects. RESULTS:We developed the Medicine Safety Code (MSC) service, a novel pharmacogenomics decision support system, to provide physicians and patients with the ability to represent pharmacogenomic data in computable form and to provide pharmacogenomic guidance at the point-of-care. Pharmacogenomic data of individual patients are encoded as Quick Response (QR) codes and can be decoded and interpreted with common mobile devices without requiring a centralized repository for storing genetic patient data. In this paper, we present the first fully functional release of this system and describe its architecture, which utilizes Web Ontology Language 2 (OWL 2) ontologies to formalize pharmacogenomic knowledge and to provide clinical decision support functionalities. CONCLUSIONS:The MSC system provides a novel approach for enabling the implementation of personalized medicine in clinical routine.
first_indexed 2024-04-12T04:05:36Z
format Article
id doaj.art-cab799ce92d14728a38125e652126b88
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T04:05:36Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-cab799ce92d14728a38125e652126b882022-12-22T03:48:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0195e9376910.1371/journal.pone.0093769An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care.Jose Antonio Miñarro-GiménezKathrin BlagecRichard D BoyceKlaus-Peter AdlassnigMatthias SamwaldBACKGROUND:The development of genotyping and genetic sequencing techniques and their evolution towards low costs and quick turnaround have encouraged a wide range of applications. One of the most promising applications is pharmacogenomics, where genetic profiles are used to predict the most suitable drugs and drug dosages for the individual patient. This approach aims to ensure appropriate medical treatment and avoid, or properly manage, undesired side effects. RESULTS:We developed the Medicine Safety Code (MSC) service, a novel pharmacogenomics decision support system, to provide physicians and patients with the ability to represent pharmacogenomic data in computable form and to provide pharmacogenomic guidance at the point-of-care. Pharmacogenomic data of individual patients are encoded as Quick Response (QR) codes and can be decoded and interpreted with common mobile devices without requiring a centralized repository for storing genetic patient data. In this paper, we present the first fully functional release of this system and describe its architecture, which utilizes Web Ontology Language 2 (OWL 2) ontologies to formalize pharmacogenomic knowledge and to provide clinical decision support functionalities. CONCLUSIONS:The MSC system provides a novel approach for enabling the implementation of personalized medicine in clinical routine.http://europepmc.org/articles/PMC4008421?pdf=render
spellingShingle Jose Antonio Miñarro-Giménez
Kathrin Blagec
Richard D Boyce
Klaus-Peter Adlassnig
Matthias Samwald
An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care.
PLoS ONE
title An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care.
title_full An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care.
title_fullStr An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care.
title_full_unstemmed An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care.
title_short An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care.
title_sort ontology based mobile optimized system for pharmacogenomic decision support at the point of care
url http://europepmc.org/articles/PMC4008421?pdf=render
work_keys_str_mv AT joseantoniominarrogimenez anontologybasedmobileoptimizedsystemforpharmacogenomicdecisionsupportatthepointofcare
AT kathrinblagec anontologybasedmobileoptimizedsystemforpharmacogenomicdecisionsupportatthepointofcare
AT richarddboyce anontologybasedmobileoptimizedsystemforpharmacogenomicdecisionsupportatthepointofcare
AT klauspeteradlassnig anontologybasedmobileoptimizedsystemforpharmacogenomicdecisionsupportatthepointofcare
AT matthiassamwald anontologybasedmobileoptimizedsystemforpharmacogenomicdecisionsupportatthepointofcare
AT joseantoniominarrogimenez ontologybasedmobileoptimizedsystemforpharmacogenomicdecisionsupportatthepointofcare
AT kathrinblagec ontologybasedmobileoptimizedsystemforpharmacogenomicdecisionsupportatthepointofcare
AT richarddboyce ontologybasedmobileoptimizedsystemforpharmacogenomicdecisionsupportatthepointofcare
AT klauspeteradlassnig ontologybasedmobileoptimizedsystemforpharmacogenomicdecisionsupportatthepointofcare
AT matthiassamwald ontologybasedmobileoptimizedsystemforpharmacogenomicdecisionsupportatthepointofcare